Prostate Cancer and Prostatic Diseases
Springer Nature Β· United Kingdom Β· Est. 1972
β Indexed in the Web of Science Core Collection (SCIE) β Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.
See the official Impact Factor & quartile on the journalβs page βThe Impact Factor & JCR quartile are licensed by Clarivate β we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q1. Source: Clarivate Journal Citation Reports.
Aims & Scope
Prostate Cancer and Prostatic Diseases covers all aspects of prostatic diseases, in particular prostate cancer, the subject of intensive basic and clinical research world-wide. The journal also reports on exciting new developments being made in diagnosis, surgery, radiotherapy, drug discovery and medical management. Prostate Cancer and Prostatic Diseases is of interest to surgeons, oncologists and clinicians treating patients and to those involved in research into diseases of the prostate. The journal covers the three main areas - prostate cancer, male LUTS and prostatitis. Prostate Cancer and Prostatic Diseases publishes original research articles, reviews, topical comment and critical appraisals of scientific meetings and the latest books. The journal also contains a calendar of forthcoming scientific meetings. The Editors and a distinguished Editorial Board ensure that submitted articles receive fast and efficient attention and are refereed to the highest possible scientific standard. A fast track system is available for topical articles of particular significance. The following is a non-exhaustive list of the general topics covered by Prostate Cancer and Prostatic Diseases : Alternative therapies Angiogenesis Anti-sense oligonucleotides against growth factors Brachytherapy Conformal radiotherapy Conformal radiotherapy Cyclotron fast neutron treatment Enhancing the results of radical prostatectomy Epidemiology of prostate cancer and prostatic diseases Familial prostate cancer Free to total PSA Gene therapy for prostate cancer Genetic basis for prostate cancer Hormone-related disease How significant is PSA-detected disease? Intermittent antiandrogen therapy Mechanisms of tumour invasion in prostate cancer Medical and surgical therapies for male LUTS Medical therapy for male LUTS: the road ahead Natural history of prostate cancer and prostatic diseases Nutrition in prostate cancer and prostatic diseases Photodynamic therapy Prognostic markers Prostate cancer and potency and impotence Prostatic intra-epithelial neoplasia - an important precursor of cancer Prostatitis: quo vadis? Quality of life issues Racial issues in prostate cancer Recurrence after radical prostatectomy Reproducibility (test-retest reliability) of investigations for prostatic diseases Reverse transcriptase polymerase chain reaction to detect circulating mRNA for PSA Role of differentiation therapy Screening for prostate cancer Staging of prostate cancer: beyond conventional imaging The magic bullet - use of PSA promotor gene to target gene therapy Utility of ultrasensitive PSA assays
General Information
Submission Info
Ethics & Quality
Think.Check.Submit Compliance
Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.
Publication & Citation Trend
Source: OpenAlex Β· Each yearβs green bar = citations earned by that yearβs papers, counted to date β so recent years look lower simply because their papers havenβt had time to be cited yet.
SJR Quartile by Discipline
Scimago ranks this journal separately in each subject category β its quartile can differ by discipline.
Subject Classification
Web of Science Categories
Scopus Categories
Research Topics (OpenAlex)
Frequently asked questions about Prostate Cancer and Prostatic Diseases
Is Prostate Cancer and Prostatic Diseases a predatory journal?
PubScope has no integrity flags on record for Prostate Cancer and Prostatic Diseases: it is indexed in Web of Science, Scopus, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 96/100. Indexing is a transparency signal, not a guarantee β always confirm fit and policies before submitting.
What is the impact factor of Prostate Cancer and Prostatic Diseases?
Prostate Cancer and Prostatic Diseases is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal β including Arts & Humanities and Emerging Sources titles β receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 4.40.
Is Prostate Cancer and Prostatic Diseases indexed in Scopus and Web of Science?
Prostate Cancer and Prostatic Diseases is indexed in Web of Science, Scopus.
What is the aims and scope of Prostate Cancer and Prostatic Diseases?
Prostate Cancer and Prostatic Diseases covers all aspects of prostatic diseases, in particular prostate cancer, the subject of intensive basic and clinical research world-wide. The journal also reports on exciting new developments being made in diagnosis, surgery, radiotherapy, drug discovery and medical management. Prostate Cancer and Prostatic Diseases is of interest to surgeons, oncologists and clinicians treating patients and to those involved in research into diseases of the prostate. The journal covers the three main areas - prostate cancer, male LUTS and prostatitis. Prostate Cancer and
You May Also Like
See all βData updated: 2026-05-22 Β· Sources: SJR, DOAJ, OpenAlex, WoS, Crossref